Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Y-box binding protein 1 pseudogene 8 (YBX1P8) is annotated as a pseudogene related to Y-box binding protein 1 (YBX1). Pseudogenes are DNA sequences similar to known genes but typically non-functional due to mutations or truncations. YBX1P8 is present in the genome and named for its homology to YBX1; however, there is no evidence that YBX1P8 encodes a functional protein or acts as a direct therapeutic target. The canonical YBX1 is a well-studied DNA/RNA-binding protein with roles in transcriptional and translational regulation, cancer biology, and cellular stress responses[1][3], but YBX1P8 specifically refers to a related, non-coding pseudogene, and there is currently no literature supporting YBX1P8 involvement in disease, drug action, or use as a biomarker[4]. Key points: - **YBX1P8** is not a receptor, enzyme, transporter, transcription factor, or histone modification enzyme, but rather a pseudogene ("Other")[4]. - There is no evidence that YBX1P8 is expressed, functionally relevant, or characterized as a therapeutic or diagnostic target[4]. - Typical molecular and clinical attributes associated with canonical therapeutic targets are not applicable to YBX1P8. - If your query pertains to the canonical **Y-box binding protein 1 (YBX1)**, refer instead to the functional protein, which is implicated in cancer and acts as a nucleic acid-binding transcription factor[1][3]. There do not appear to be any known aliases, molecular function, clinical disease roles, drug interactions, or use as a biomarker specifically for YBX1P8, confirming that the query is about a likely non-functional pseudogene rather than a validated therapeutic target[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Y-box binding protein 1 pseudogene 8 (YBX1P8).